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Slowed nerve-conduction velocities (NCVs) are a biological endophenotype in the majority of the hereditary motor
and sensory neuropathies (HMSN). Here, we identified a family with autosomal dominant segregation of slowed
NCVs without the clinical phenotype of HMSN. Peripheral-nerve biopsy showed predominantly thinly myelinated
axons. We identified a locus at 8p23 and a Thr109Ile mutation in ARHGEF10, encoding a guanine-nucleotide
exchange factor (GEF) for the Rho family of GTPase proteins (RhoGTPases). Rho GEFs are implicated in neural
morphogenesis and connectivity and regulate the activity of small RhoGTPases by catalyzing the exchange of bound
GDP by GTP. Expression analysis of ARHGEF10, by use of its mouse orthologue Gef10, showed that it is highly
expressed in the peripheral nervous system. Our data support a role for ARHGEF10 in developmental myelination
of peripheral nerves.
The phenotype of slowed motor and sensory nerve-con-
duction velocities (NCVs) in a 4-generation family (De
Jonghe et al. 1999) was accidentally discovered on clini-
cal and electrophysiological examination of proband
III-16 for vascular problems of the leg. Subsequent ex-
amination identified slowed NCVs in 12 of 39 healthy
relatives (5 males and 7 females), indicating an auto-
somal dominant inheritance of the phenotype (fig. 1A).
NCVs were uniformly slowed in all nerves examined;
34–42 m/s for motor median nerve (normal 49 m/s),
27–36 m/s for motor peroneal nerve (normal 41 m/s),
32–46 m/s for sensory median nerve (normal 46 m/s),
33–45 m/s for sensory ulnar nerve (normal 46 m/s),
and 28–35 m/s for sensory sural nerve (normal 44 m/
s). Compound muscle-action potentials were normal,
and sensory nerve–action potentials were sometimes
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slightly reduced. None of the affected family members
showed any clinical signs of peripheral or CNS dys-
function. The eldest individuals, II-4 and II-7 (aged 87
and 78 years, respectively, at time of neurological ex-
amination), had NCVs that were not significantly dif-
ferent from those measured in younger affected individ-
uals. Histological studies of a peripheral-nerve biopsy of
proband III-16 at age 54 years showed numerous rela-
tively thin myelin sheaths (mean g-ratio: 0.75 for mye-
linated fibers, with a range of 2–7 mm) (fig. 1B), slight
onion-bulb formation, and few axonal-regeneration
clusters (De Jonghe et al. 1999).
We performed a 10-cM density genomewide linkage
analysis and obtained a conclusive linkage with D8S264
on chromosome 8p23 (table 1). The region around
D8S264 was saturated with known and novel micro-
satellite markers, and a maximum LOD score of 9.33,
at recombination fraction (v) 0, was calculated with
marker AF009213 (table 1). Haplotype analysis iden-
tified meiotic recombinants, with STR2 and D8S504 re-
stricting the candidate region to 1.5 Mb, on the basis
of sequence contigs NT_008060, NT_037694, and
NT_023744 (NCBI, LocusLink) (fig. 2a). Within the se-
quence, a total of five known genes was identified, which
Figure 1 Haplotype analysis of chromosome 8p23 STR markers. a, Pedigree of the family with slowed NCVs. Squares p male; circles
p female; unblackened p unaffected; blackened p reduced nerve conduction phenotype; slashed p deceased; diagonal arrow p proband.
Blood samples were obtained after informed consent and approval of the Committee for Medical Ethics, University of Antwerp. A genomewide
scan was performed using 382 STR markers from the ABI Prism Linkage Mapping, Set MD-10 (Applied Biosystems). Conclusive linkage was
found with D8S264. Additional STR markers were used in the fine mapping: three known markers (D8S504, AF009208, and AF009213) and
four novel STR markers (designated “STR1,” “STR2,” “STR3,” and “STR4”) (table A [online only]). Genotypes are represented by allele
numbers; “0 0” p failed genotype. For each STR marker, a disease haplotype was constructed (box). The presence of the Thr109Ile mutation
is indicated by a plus sign (), the absence by a minus sign (). The meiotic recombination events, indicated with an arrow, assign the disease
locus to the chromosome segment contained between D8S504 and STR2. b, Electron microscopy. Transverse section of superficial fibular nerve
shows thinly myelinated fibers (arrows). Scale bar p 10 mm.
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Table 1
Two-Point Linkage Results with Chromosome 8p23 Markers
MARKER
LOD AT v p
0 .001 .01 .05 .1 .2 .3 .4
STR1 6.32 6.31 6.22 5.81 5.26 4.05 2.68 1.19
D8S504  6.20 7.07 7.20 6.76 5.44 3.79 1.87
AF009208 6.98 6.97 6.87 6.41 5.82 4.58 3.19 1.60
D8S264 3.01 3.01 2.96 2.77 2.51 1.95 1.34 .68
Thr109Ile 9.93 9.91 9.78 9.17 8.37 6.64 4.68 2.46
AF009213 9.33 9.32 9.19 8.60 7.82 6.14 4.24 2.09
STR2  4.39 5.28 5.51 5.19 4.15 2.84 1.34
STR3  4.27 5.18 5.44 5.18 4.25 3.02 1.53
STR4  5.36 6.25 6.43 6.05 4.90 3.44 1.72
NOTE.—Two-point linkage analysis was performed with the
MLINK program of the FASTLINK program package (Lathrop and
Lalouel 1984; Cottingham et al. 1993). Since NCV values were di-
agnostic in all individuals, the phenotype was coded as a 100% pen-
etrant phenotype (De Jonghe et al. 1999). The gene frequency was set
at 0.0001, allele frequencies were set at (N p number of alleles1/N
observed in the pedigree), and equal recombination rates between
males and females were assumed. (Sequences of the four new STR
markers [STR1, STR2, STR3, and STR4] shown in table A [online
only].)
we analyzed for mutations by genomic sequencing of
exons and flanking splice sites in two affected individuals
and two control individuals: KIAA0711 (hypothetic-
al protein KIAA0711 [GenBank accession number
NM_014867]), MYOM2 (myomesin [M-protein] 2
[GenBank accession number NM_003970]), CLN8 (cer-
oid-lipofuscinosis, neuronal 8 [GenBank accession num-
ber NM_018941]), DLGAP2 (discs, large [Drosophila]
homolog-associated protein 2 [GenBank accession num-
ber NM_004745]), and ARHGEF10 (Rho guanine-nu-
cleotide exchange [GEF] factor 10 [GenBank acces-
sion number NM_014629]) (intronic primers for
ARHGEF10 shown in table B [online only]). A hetero-
zygous mutation, CrT (c.326CrT; g.6110CrT), was
observed in exon 3 of ARHGEF10, encoded by 22 ex-
ons, as shown by sequence alignment of its 8,467-bp
transcript (GenBank accession number NM_014629),
with the genomic sequence contained in NT_023744
(fig. 2b). The presence of the mutation was confirmed
by BanI digestion of PCR-amplified exon 3, generating
one mutant fragment of 329 bp and two wild-type frag-
ments of 172 bp and 157 bp. Complete cosegregation
of the mutation was observed in the family (LODp
) (fig. 1; table 1), and the mutation was absent in9.93
600 control chromosomes. The mutation predicts an
amino acid substitution of threonine (Thr) to isoleucine
(Ile) at codon 109 (Thr109Ile) of the ARHGEF10 pro-
tein (GenBank accession number NP_055444). Clustal
W protein alignment of the human ARHGEF10 pro-
tein—with its orthologues in macaque (GenBank acces-
sion number BAB12119), puffer fish (GenBank acces-
sion number FuguGenscan_7637), and mouse (Gef10)
(GenBank accession number NP_766339)—showed that
Thr109 is a conserved amino acid in all four species
(table C [online only]). Screening of patients with dif-
ferent clinical subtypes of Charcot-Marie-Tooth disease
did not identify mutations in ARHGEF10. This is not
unexpected, given that the individuals in our family were
clinically unaffected and had minor disturbances in
NCVs and myelination.
We examined expression of ARHGEF10, using its
mouse orthologue, Gef10. Alignment of the Gef10
transcript of 4,481 bp (GenBank accession number
NM_172751) with the genomic sequence NT_039455
identified 24 exons; exons 1 and 2 were absent from
ARHGEF10 (fig. 2b). Multiple-tissue northern blot
analysis of Gef10 indicated ubiquitous expression (data
not shown). Overlapping primer sets covering the mouse
cDNA sequence were used in PCR analysis on cDNA of
E13 mouse brain, dorsal root ganglia (DRG), and ven-
tral horn (VH) and demonstrated Gef10 expression in
all three neuronal tissues. Extra PCR fragments that in-
dicated the presence of alternative transcripts were ob-
served (fig. 2c–2e). Sequencing of these fragments iden-
tified three splice variants of Gef10: one in all three
tissues missing exon 4 (fig. 2c), one specific for DRG
missing exon 21 (fig. 2d), and one specific to VH, with
an insertion of an additional exon of 165 bp between
exons 22 and 23 (fig. 2e). Exon 5, which corresponds
to exon 3 in ARHGEF10 and contains the Thr109Ile
mutation, is present in all three variant transcripts.
Whole-mount in situ hybridization experiments in
mouse embryos at E8.5 showed Gef10 expression in the
neuroepithelium of the meninges, including the optic sul-
cus (fig. 3a and 3b). At E9.5, high levels of Gef10 ex-
pression were detected in the roof plate of the rhom-
bencephalon (fig. 3c and 3d). In E12.5 embryos, Gef10
is ubiquitously expressed, with a pronounced expression
in the neuroepithelium of brain vesicles, the neural tube,
the ganglia, DRG, and the neural layer of retina (fig.
3e–3h).
ARHGEF10 encodes a guanine-nucleotide exchange
factor for the Rho family of GTPase proteins (RhoGEFs)
and contains a Dbl homology (DH) domain (codons
177–359), a common feature of all RhoGEFs (Zheng
2001). RhoGEFs activate RhoGTPases by catalyzing the
exchange of bound GDP for GTP, which induces a con-
formational change in the GTP-bound GTPase that al-
lows its interaction with downstream effector proteins
(Bourne et al. 1990; Boguski and McCormick 1993;
Hart et al. 1994). Within the RhoGEF family, DH do-
mains are invariably followed by a pleckstrin homology
(PH) domain, supposed to be involved in subcellular
localization of RhoGEFs (Hoffman and Cerione 2002).
However, in ARHGEF10, we could not detect a PH-
domain consensus motif using several bioinformatic
tools (BlastP, ScanProsite, or InterPro). So far, only one
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Figure 2 Positional cloning and expression analysis of ARHGEF10. a, Linked region on chromosome 8p23. Meiotic recombinants with
STR2 and D8S504 defined a critical region of 1.5 Mb. Shaded boxes indicate the five known genes in the region. b, Genomic structure of
human ARHGEF10 and mouse Gef10, aligned. The 5′ and 3′ UTRs are light gray; the Dbl domain is dark gray. An arrow indicates the position
of the Thr109Ile mutation. c–e, Expression analysis of mouse Gef10 on cDNA of motor and sensory neurons isolated from VH and DRG of
mice embryos, age 13 d. Expression analysis was performed with oligonucleotide primer pairs spread over the proximal, middle, and distal
part of the gene. Subsequent direct-DNA sequencing analysis of PCR fragments was performed. M p 100-bp size marker (Invitrogen); Br p
mouse brain cDNA (Clontech); VH p VH cDNA; DRG p DRG cDNA; C p blanco. c, cDNA primer1 and primer2, splicing of exon 4 in
the smaller fragment in brain, VH, and DRG. d, cDNA primer3 and primer4, skipping of exon 21 in DRG. e, cDNA primer5 and primer6,
additional exon identified, located between exon 22 and 23 in VH. (Primer sequences shown in table D [online only].)
other mammalian RhoGEF family member, p164-
RhoGEF, lacking the PH domain has been reported (Ru-
menapp et al. 2002). ARHGEF10 appears to lack an
equivalent protein in Caenorhabditis elegans, Droso-
phila melanogaster, Dictyostelium discoideum, and
Saccharomyces cerevisiae, which suggests that the
ARHGEF10 signaling pathway is unique to vertebrates.
This confirms the overall picture of plasticity, when com-
paring the RhoGTPases and their interacting proteins
between species, with certain species gaining or losing
RhoGTPase and RhoGEF family members to give rise
to unique sets of signaling proteins (Wherlock and Mel-
lor 2002). RhoGTPases play a pivotal role in regulating
the actin cytoskeleton, but their ability to influence cell
polarity, microtubule dynamics, membrane-transport
pathways, and transcription-factor activity is probably
just as significant (Etienne-Manneville and Hall 2002).
Recent evidence has implicated RhoGTPases in neuronal
morphogenesis, including cell migration, axonal growth
and guidance, dendrite elaboration and plasticity, and
synapse formation. Several GEFs play a central role in
defining the temporal and spatial activation of the cor-
responding GTPase within neuronal cells (Etienne-Man-
neville and Hall 2002).
Here, we report a Thr109Ile mutation in ARHGEF10
cosegregating with slowed NCVs of peripheral nerves
Figure 3 Expression pattern of Gef10 mRNA in mouse embryo. a and b, Frontal view on an E8.5 embryo (a) and blowup of the head
region (b) hybridized with the GEF10 probe. GEF10 mRNA is expressed in the neuroepithelium (ne) of brain vesicles and optic stalk (os). c
and d, Dorsal (c) and lateral (d) views on an E9.5 embryo. High levels of GEF10 mRNA are observed in the thin roof of the rhombencephalon
(trr), the neuroepithelium lining the brain ventricles, and, to a lesser extend, in the neural tube (nt). e–h, Bright-field (e) and corresponding
dark-field image (f) of a transversal section at the level of the epithalamus of E12.5 embryo. Transcripts of GEF10 are present in the ependymal
layer (el) of neural tube and brain vesicles, as well as in the trigeminal ganglia (tg) of the head. GEF10 transcripts are also detected in the
endolymphatic sac (es) and semicircular canal (ssc). g, Dark-field image of a transversal section through the neural tube. Note high expression
in the ependymal layer of the neural tube and the DRG. h, Transversal section through the region of the eye at E12.5, revealing very high
GEF10 expression levels in the neural layer of the retina (nlr). can(XI)p cranial accessory (XI) nerve; tg(V)p trigeminal (V) ganglion; vcg(VIII)
p vestibulocochlear (VIII) ganglion; ov p otic vesicle; l p lens; lge p lateral ganglionic eminence; lb p limb bud. The whole-mount and
radioactive in situ hybridizations were performed as reported elsewhere (Wilkinson 1992; Dewulf et al. 1995).
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without clinical phenotype in a 4-generation family.
RhoGEFs have been implicated elsewhere in human ge-
netic disorders. A mutation in the DH domain of FGD1
GEF cosegregates with faciogenital dysplasia, a devel-
opmental disorder (Pasteris et al. 1994). Mutations in
ARHGEF6 (also known as “aPIX”) are associated with
X-linked nonsyndromic mental retardation (Kutsche et
al. 2000). Loss-of-function mutations in the ALS2 (alsin)
gene cause autosomal recessive amyotrophic lateral scle-
rosis (ALS2), a neurodegenerative disorder affecting the
large motor neurons of the CNS (Hadano et al. 2001;
Yang et al. 2001). The identification of ARHGEF10 as
a gene implicated in peripheral-nerve conduction raises
questions about its role during the development of the
peripheral nervous system in vertebrates. All affected
individuals in the family had slowed NCVs with normal
amplitudes at all ages, which indicates that the pheno-
type is nonprogressive. Together with the numerous thin
myelinated axons in the absence of gross signs of de-
myelination or axonal degeneration and regeneration in
the peripheral nerve biopsy of the proband, these ob-
servations are indicative of a congenital nonprogressive
phenotype, which suggests that ARHGEF10 is most
likely involved in normal development of peripheral
nerves, though its actual biological function remains to
be elucidated. Also, the upstream signaling cascade nec-
essary for ARHGEF10 activation and the RhoGTPase
subsequently activated by ARHGEF10 remain to be
clarified.
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